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procedures recorded was 0.6 per patient and the number of
hemodialysis related hospitalizations was 0.3 per patient.
Among patients who underwent creation of RCF, the average
number of central venous catheter days was 83.4 days per
patient, the average number of fistula related procedures re-
corded was 1.8 per patient and the average number of hemo-
dialysis related hospitalizations was 0.8 per patient. There was
a statistically significant difference postoperative course be-
tween those patients who underwent BCF versus RCF
creation.
Conclusions: Patients greater than 68 years of age who
undergoRCFcreationmayhave agreater likelihoodof increased
central venous catheterdays, a greaternumberofhospitalizations
related to hemodialysis access and a greater number of postoper-
ative procedures than those who undergo BCF creation.
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Objectives: Treatment of patients with arch, TAAA
and chronic dissection is challenging.We report the results
of FEVAR of such aneurysms.
Methods: A single center prospective FEVAR trial
enrolled 356 patients(2006-11), of which 29 had chronic
dissections with arch and/or TAAA. Patients were divided
into a group with extensive dissections from the arch
through the visceral segment(Group A, n  15, mean age
57y), and a group with focal dissections(Group B, n  14,
mean age 73y).Customized grafts were implanted into the
true lumen, from which all supra-aortic trunk(arch branch
devices) and visceral vessels were supplied.Patients were
followed annually with imaging and laboratory studie-
s.Outcome analyses included survival, rupture, spinal cord
ischemia, endoleak, morbidity(cardiac, renal, pulmonary),
secondary interventions, dissection and aneurysm growth.
Results: Mean time between dissection and FEVAR
was 10.6 years, and aneurysm size was 61mm. Follow-up
averaged 1.7 years. There were no perioperativemortalities,
and one aortic related death at 90 days due to progression
of pre-existing untreated arch dissection. No ruptures,
cardiac, renal, paraplegia or pulmonary complications oc-
curred. Despite narrow true lumen dimensions, stentgrafts
expanded to their nominal diameters in all cases without
graft compression. Post FEVAR growth was noted in
two cases (one Marfan/one LDS), related to type II
endoleaks. Sac regression was similar (7.5mm vs
10.1mm). Early secondary interventions were more
common in group A, occurring in 7 patients (all endo-
vascular). Younger patients, and those with a defined
connective tissue disease (Marfans/LDS) were more
commonly in Group A (P.001).
Conclusions: FEVAR is feasible for patients with
chronic dissections with arch and TAAA.Visceral vessel
access and graft compression resulting from narrow true
lumen diameters were not problems in this select popula-
tion.Favorable sac and lumen morphologic changes cou-
pled with lowmortality and complication risk makes this an
attractive treatment option.
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Objectives: Finite Element (FE) Analysis has been used
to estimate peak wall stress(PWS) and peak wall rupture
risk(PWRR) of Abdominal Aortic Aneurysms(AAA).
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However, these values are not familiar for Clinicians. The aim of
this study was to introduce a patient specific and clinically appli-
cable biomechanical rupture risk assessment tool that would be
easy for Vascular Surgeons to comprehend.
Methods: Clinical data(gender, age, Smoking, chronic
obstructive lung disease, mean arterial pressure, family his-
tory) and CT images were retrospectively gathered from
200(142male, 44 female) non ruptured AAA patients from 4
different hospitals in Sweden, Belgium and Germany. FE
models were created using the diagnostics system A4 Clinics
(VASCOPS, Austria) and the maximum diameter, PWS and
PWRR was calculated automatically. Statistical analysis was
performed with Mathematica (Wolfram Research Inc, USA).
Results: The maximum diameter was normally distrib-
uted in males and females and no difference was found be-
tween PWS levels in men and women (P  .091) but the
PWRR was higher in women (P .005). PWS increased in a
linear fashion and PWRR exponentially with diameter. We
then relatedPWRRto themaximumdiameters of patients and
calcuated the Rupture Risk Equvialent diameter (RRED) as
shown in the figure. A PWRR of 0.48 corresponds to an
RRED of 55 millimeters.
Conclusions: Biomechanical AAA rupture risk assess-
ment integrates risk based on clinical parameters and data
from CT images. The RRED expresses this information as
a diameter that is comprehensible for clinicians.
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Objectives:The FDA is collaborating with clinicians to
characterize human aortic anatomy in a population-based
study, CHAP, to increase patient eligibility for EVAR and
augment endograft (EVG) design and evaluation.
Methods: Preoperative CT scans from three centers
were prospectively entered into a database from 7/96 to
8/10. A blinded third-party, M2S, recorded 25 standard-
ized measurements from the 3D reconstructions. For in-
clusion, AAA had to be infrarenal and 5 cm, or 4-5 cm if
the orthogonal sac diameter was more than twice the
normal aortic diameter. The anatomic criteria were ana-
lyzed in 1108 men and 357 women with untreated AAA.
Results: Anatomy of men and women with AAA is
significantly different in each age category (P.005) except
for neck length and angulation in the youngest group*.
The aortic neck shortens and becomesmore angulated with
age (P.005), especially for women. Other differences
between men and women are more consistent by age
group.
Conclusions: Almost all the key anatomic parameters
are significantly different between men and women. Some
anatomic differences are independent of age, but the dis-
parity in neck length, angulation and access becomes more
apparent as patients age, with women having more severe
anatomy at all ages. All of these factors lower EVAR eligi-
bility for older patients, especially women, with only 29% of
women over 80 years eligible for EVAR based on current
EVG’s Instructions for Use.
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Table. Mean (and 10th-90th percentile range) anatomic parameters by gender and age
Years
Women Men
 69 70–79  80  69 70–79  80
Neck diameters, mm 24 20–29 24 18–34 24 19–30 26 21–33 26 21–32 26 21–32
Neck length, mm 17* 4–32 14 4–31 13 3–30 19* 5–35 17 4–35 18 5–39
Angle, deg 38* 17–58 46 27–74 50 27–64 35* 18–57 38 18–61 41 19–65
Ao bifurcation diameter, mm 20 12–28 19 12–30 19 13–27 24 15–35 22 15–33 22 15–32
Min com iliac diameter, mm 11 7–15 11 8–14 11 8–15 14 10–19 14 11–19 12 11–15
Ave ext iliac diameter, mm 6 5–8 7 5–9 7 5–8 8 7–10 9 7–11 9 7–11
Min iliac access, mm 5 3–7 5 4–7 5 4–7 7 6–9 7 6–10 8 5–10
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